LectinStars Pharmaceuticals won the third place in the Innovation Challenge of 2022 NBRP DEMO DAY.
LectinStars Pharmaceuticals's core research product "SP-2021A (Anti-Siglec-3 (CD33) antibody for healing Chronic Hepatitis B) won the third prize in the Innovation Challenge of 2022 NBRP DEMO DAY.